AAAAAA
Results:
1-19
|
Results: 19
Authors:
GOLDHIRSCH A
GLICK JH
GELBER RD
SENN HJ
Citation: A. Goldhirsch et al., MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER, Journal of the National Cancer Institute, 90(21), 1998, pp. 1601-1608
CONCURRENT CHEMOTHERAPY AND RADIATION FOR BREAST-CONSERVATION TREATMENT OF EARLY-STAGE BREAST-CANCER
Authors:
MARKIEWICZ DA
FOX KR
SCHULTZ DJ
HARRIS EER
HAAS JA
GLICK JH
SOLIN LJ
Citation: Da. Markiewicz et al., CONCURRENT CHEMOTHERAPY AND RADIATION FOR BREAST-CONSERVATION TREATMENT OF EARLY-STAGE BREAST-CANCER, The cancer journal from Scientific American, 4(3), 1998, pp. 185-193
Authors:
WIERNIK PH
MOORE DF
BENNETT JM
VOGL SE
HARRIS JE
LUGER S
OKEN MM
GLICK JH
Citation: Ph. Wiernik et al., PHASE-II STUDY OF MITOGUAZONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE FOR PATIENTS WITH DIFFUSE HISTOLOGIC SUBTYPES OF NON-HODGKINS-LYMPHOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (PE481), Leukemia & lymphoma, 30(5-6), 1998, pp. 601-607
Authors:
GLICK JH
YOUNG ML
HARRINGTON D
SCHILSKY RL
BECK T
NEIMAN R
FISHER RI
PETERSON BA
OKEN MM
Citation: Jh. Glick et al., MOPP ABV HYBRID CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE SIGNIFICANTLY IMPROVES FAILURE-FREE AND OVERALL SURVIVAL - THE 8-YEAR RESULTS OFTHE INTERGROUP TRIAL/, Journal of clinical oncology, 16(1), 1998, pp. 19-26
Authors:
SPARANO JA
NEUBERG D
GLICK JH
ROBERT NJ
GOLDSTEIN LJ
SLEDGE GW
WOOD W
Citation: Ja. Sparano et al., PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(5), 1997, pp. 1880-1884
Authors:
OKEN MM
HARRINGTON DP
ABRAMSON N
KYLE RA
KNOSPE W
GLICK JH
Citation: Mm. Oken et al., COMPARISON OF MELPHALAN AND PREDNISONE WITH VINCRISTINE, CARMUSTINE, MELPHALAN, CYCLOPHOSPHAMIDE, AND PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - RESULTS OF EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY E2479, Cancer, 79(8), 1997, pp. 1561-1567
Authors:
MAYER RJ
ANTMAN KH
BAILES JS
BLOOMFIELD CD
CANELLOS GP
GLICK JH
JACOBS CD
Citation: Rj. Mayer et al., STATUS OF THE MEDICAL ONCOLOGY WORKFORCE, Journal of clinical oncology, 14(9), 1996, pp. 2612-2621
Authors:
GLICK JH
Citation: Jh. Glick, AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY - A SOCIETY IN TRANSITION, Journal of clinical oncology, 14(8), 1996, pp. 2388-2398
Authors:
MARKIEWICZ DA
SCHULTZ DJ
HAAS JA
HARRIS EER
FOX KR
GLICK JH
SOLIN LJ
Citation: Da. Markiewicz et al., THE EFFECTS OF SEQUENCE AND TYPE OF CHEMOTHERAPY AND RADIATION-THERAPY ON COSMESIS AND COMPLICATIONS AFTER BREAST-CONSERVATION THERAPY, International journal of radiation oncology, biology, physics, 35(4), 1996, pp. 661-668
Authors:
GOLDHIRSCH A
WOOD WC
SENN HJ
GLICK JH
GELBER RD
Citation: A. Goldhirsch et al., MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER, Journal of the National Cancer Institute, 87(19), 1995, pp. 1441-1445
Authors:
GOLDHIRSCH A
WOOD WC
SENN HJ
GLICK JH
GELBER RD
Citation: A. Goldhirsch et al., INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER, European journal of cancer, 31A(11), 1995, pp. 1754-1759
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN CM
UNGERLEIDER JS
EMERSON WA
TORMEY DC
GLICK JH
VEEDER MH
MAILLIARD JA
Citation: Cg. Moertel et al., INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2936-2943
Authors:
MOERTEL CG
FLEMING TR
MACDONALD JS
HALLER DG
LAURIE JA
TANGEN CM
UNGERLEIDER JS
EMERSON WA
TORMEY DC
GLICK JH
VEEDER MH
MAILLIARD JA
GRAFF J
Citation: Cg. Moertel et al., FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT, Annals of internal medicine, 122(5), 1995, pp. 321-326
Authors:
COLGAN JP
ANDERSEN J
HABERMANN TM
EARLE JD
OCONNELL MJ
NEIMAN RS
MANN RB
GLICK JH
Citation: Jp. Colgan et al., LONG-TERM FOLLOW-UP OF A CHOP-BASED REGIMEN WITH MAINTENANCE THERAPY AND CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN LYMPHOBLASTIC NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 15(3-4), 1994, pp. 291-296
Authors:
COLGAN JP
ANDERSEN J
HABERMANN TM
EARLE JD
OCONNELL MJ
NEIMAN RS
MANN RB
GLICK JH
Citation: Jp. Colgan et al., LONG-TERM FOLLOW-UP OF A CHOP-BASED REGIMEN WITH MAINTENANCE THERAPY AND CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN LYMPHOBLASTIC NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 15(3-4), 1994, pp. 291-296
Authors:
FISHER RI
GAYNOR ER
DAHLBERG S
OKEN MM
GROGAN TM
MIZE EM
GLICK JH
COLTMAN CA
MILLER TP
Citation: Ri. Fisher et al., A PHASE-III COMPARISON OF CHOP VS M-BACOD VS PROMACE-CYTABOM VS MACOP-B IN PATIENTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF SWOG-8516 (INTERGROUP 0067), THE NATIONAL HIGH-PRIORITY LYMPHOMA STUDY, Annals of oncology, 5, 1994, pp. 190000091-190000095
Authors:
FOWBLE BL
SCHULTZ DJ
OVERMOYER B
SOLIN LJ
FOX K
JARDINES L
OREL S
GLICK JH
Citation: Bl. Fowble et al., THE INFLUENCE OF YOUNG AGE ON OUTCOME IN EARLY-STAGE BREAST-CANCER, International journal of radiation oncology, biology, physics, 30(1), 1994, pp. 23-33
Authors:
ADKINSON NF
ALPERT JS
LORIAUX DL
LADENSON PW
FRIEDMAN LS
CASSILETH PA
KAUFMAN RE
BARTLETT JG
KLEMPNER MS
NEILSON EG
GLICK JH
MAYER RJ
KOERNER SK
CRANDALL ED
AREND WP
Citation: Nf. Adkinson et al., TRAINING IN SUBSPECIALTY INTERNAL-MEDICINE - ON THE CHESSBOARD OF HEALTH-CARE REFORM, Annals of internal medicine, 121(10), 1994, pp. 810-813
Authors:
BENNETT JM
ANDERSEN JW
BEGG CB
GLICK JH
Citation: Jm. Bennett et al., AGE AND HODGKINS-DISEASE - THE IMPACT OF COMPETING RISKS AND POSSIBLYSALVAGE THERAPY ON LONG-TERM SURVIVAL - AN ECOG STUDY, Leukemia research, 17(10), 1993, pp. 825-832
Risultati:
1-19
|